639 related articles for article (PubMed ID: 28818206)
1. Pharmacological and Activated Fibroblast Targeting of Gβγ-GRK2 After Myocardial Ischemia Attenuates Heart Failure Progression.
Travers JG; Kamal FA; Valiente-Alandi I; Nieman ML; Sargent MA; Lorenz JN; Molkentin JD; Blaxall BC
J Am Coll Cardiol; 2017 Aug; 70(8):958-971. PubMed ID: 28818206
[TBL] [Abstract][Full Text] [Related]
2. Inhibiting Fibronectin Attenuates Fibrosis and Improves Cardiac Function in a Model of Heart Failure.
Valiente-Alandi I; Potter SJ; Salvador AM; Schafer AE; Schips T; Carrillo-Salinas F; Gibson AM; Nieman ML; Perkins C; Sargent MA; Huo J; Lorenz JN; DeFalco T; Molkentin JD; Alcaide P; Blaxall BC
Circulation; 2018 Sep; 138(12):1236-1252. PubMed ID: 29653926
[TBL] [Abstract][Full Text] [Related]
3. Cardiac Fibroblast GRK2 Deletion Enhances Contractility and Remodeling Following Ischemia/Reperfusion Injury.
Woodall MC; Woodall BP; Gao E; Yuan A; Koch WJ
Circ Res; 2016 Oct; 119(10):1116-1127. PubMed ID: 27601479
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous adrenal and cardiac g-protein-coupled receptor-gβγ inhibition halts heart failure progression.
Kamal FA; Mickelsen DM; Wegman KM; Travers JG; Moalem J; Hammes SR; Smrcka AV; Blaxall BC
J Am Coll Cardiol; 2014 Jun; 63(23):2549-2557. PubMed ID: 24703913
[TBL] [Abstract][Full Text] [Related]
5. Small molecule disruption of G beta gamma signaling inhibits the progression of heart failure.
Casey LM; Pistner AR; Belmonte SL; Migdalovich D; Stolpnik O; Nwakanma FE; Vorobiof G; Dunaevsky O; Matavel A; Lopes CM; Smrcka AV; Blaxall BC
Circ Res; 2010 Aug; 107(4):532-9. PubMed ID: 20576935
[TBL] [Abstract][Full Text] [Related]
6. Small molecule disruption of G protein βγ subunit signaling reprograms human macrophage phenotype and prevents autoimmune myocarditis in rats.
Karuppagounder V; Bajpai A; Meng S; Arumugam S; Sreedhar R; Giridharan VV; Guha A; Bhimaraj A; Youker KA; Palaniyandi SS; Karmouty-Quintana H; Kamal F; Spiller KL; Watanabe K; Thandavarayan RA
PLoS One; 2018; 13(7):e0200697. PubMed ID: 30024944
[TBL] [Abstract][Full Text] [Related]
7. Gβγ-independent recruitment of G-protein coupled receptor kinase 2 drives tumor necrosis factor α-induced cardiac β-adrenergic receptor dysfunction.
Vasudevan NT; Mohan ML; Gupta MK; Martelli EE; Hussain AK; Qin Y; Chandrasekharan UM; Young D; Feldman AM; Sen S; Dorn GW; Dicorleto PE; Naga Prasad SV
Circulation; 2013 Jul; 128(4):377-87. PubMed ID: 23785004
[TBL] [Abstract][Full Text] [Related]
8. Paroxetine-mediated GRK2 inhibition reverses cardiac dysfunction and remodeling after myocardial infarction.
Schumacher SM; Gao E; Zhu W; Chen X; Chuprun JK; Feldman AM; Tesmer JJ; Koch WJ
Sci Transl Med; 2015 Mar; 7(277):277ra31. PubMed ID: 25739765
[TBL] [Abstract][Full Text] [Related]
9. Obesity-induced cardiac lipid accumulation in adult mice is modulated by G protein-coupled receptor kinase 2 levels.
Lucas E; Vila-Bedmar R; Arcones AC; Cruces-Sande M; Cachofeiro V; Mayor F; Murga C
Cardiovasc Diabetol; 2016 Nov; 15(1):155. PubMed ID: 27832814
[TBL] [Abstract][Full Text] [Related]
10. Myocardial Ablation of G Protein-Coupled Receptor Kinase 2 (GRK2) Decreases Ischemia/Reperfusion Injury through an Anti-Intrinsic Apoptotic Pathway.
Fan Q; Chen M; Zuo L; Shang X; Huang MZ; Ciccarelli M; Raake P; Brinks H; Chuprun KJ; Dorn GW; Koch WJ; Gao E
PLoS One; 2013; 8(6):e66234. PubMed ID: 23805205
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast-Specific Genetic Manipulation of p38 Mitogen-Activated Protein Kinase In Vivo Reveals Its Central Regulatory Role in Fibrosis.
Molkentin JD; Bugg D; Ghearing N; Dorn LE; Kim P; Sargent MA; Gunaje J; Otsu K; Davis J
Circulation; 2017 Aug; 136(6):549-561. PubMed ID: 28356446
[TBL] [Abstract][Full Text] [Related]
12. Level of G protein-coupled receptor kinase-2 determines myocardial ischemia/reperfusion injury via pro- and anti-apoptotic mechanisms.
Brinks H; Boucher M; Gao E; Chuprun JK; Pesant S; Raake PW; Huang ZM; Wang X; Qiu G; Gumpert A; Harris DM; Eckhart AD; Most P; Koch WJ
Circ Res; 2010 Oct; 107(9):1140-9. PubMed ID: 20814022
[TBL] [Abstract][Full Text] [Related]
13. GRK2 inhibition in heart failure: something old, something new.
Lymperopoulos A; Rengo G; Koch WJ
Curr Pharm Des; 2012; 18(2):186-91. PubMed ID: 22229578
[TBL] [Abstract][Full Text] [Related]
14. G protein-coupled receptor kinase 2 ablation in cardiac myocytes before or after myocardial infarction prevents heart failure.
Raake PW; Vinge LE; Gao E; Boucher M; Rengo G; Chen X; DeGeorge BR; Matkovich S; Houser SR; Most P; Eckhart AD; Dorn GW; Koch WJ
Circ Res; 2008 Aug; 103(4):413-22. PubMed ID: 18635825
[TBL] [Abstract][Full Text] [Related]
15. Targeting GPCR-Gβγ-GRK2 signaling as a novel strategy for treating cardiorenal pathologies.
Rudomanova V; Blaxall BC
Biochim Biophys Acta Mol Basis Dis; 2017 Aug; 1863(8):1883-1892. PubMed ID: 28130200
[TBL] [Abstract][Full Text] [Related]
16. G protein-coupled receptor kinase 2 activity impairs cardiac glucose uptake and promotes insulin resistance after myocardial ischemia.
Ciccarelli M; Chuprun JK; Rengo G; Gao E; Wei Z; Peroutka RJ; Gold JI; Gumpert A; Chen M; Otis NJ; Dorn GW; Trimarco B; Iaccarino G; Koch WJ
Circulation; 2011 May; 123(18):1953-62. PubMed ID: 21518983
[TBL] [Abstract][Full Text] [Related]
17. Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition.
Fraccarollo D; Galuppo P; Motschenbacher S; Ruetten H; Schäfer A; Bauersachs J
Basic Res Cardiol; 2014 Jul; 109(4):421. PubMed ID: 24907870
[TBL] [Abstract][Full Text] [Related]
18. A novel fibroblast activation inhibitor attenuates left ventricular remodeling and preserves cardiac function in heart failure.
Bradley JM; Spaletra P; Li Z; Sharp TE; Goodchild TT; Corral LG; Fung L; Chan KWH; Sullivan RW; Swindlehurst CA; Lefer DJ
Am J Physiol Heart Circ Physiol; 2018 Sep; 315(3):H563-H570. PubMed ID: 29949382
[TBL] [Abstract][Full Text] [Related]
19. Degradation of GRK2 and AKT is an early and detrimental event in myocardial ischemia/reperfusion.
Penela P; Inserte J; Ramos P; Rodriguez-Sinovas A; Garcia-Dorado D; Mayor F
EBioMedicine; 2019 Oct; 48():605-618. PubMed ID: 31594751
[TBL] [Abstract][Full Text] [Related]
20. Cardiac hyporesponsiveness in severe sepsis is associated with nitric oxide-dependent activation of G protein receptor kinase.
Dal-Secco D; DalBó S; Lautherbach NES; Gava FN; Celes MRN; Benedet PO; Souza AH; Akinaga J; Lima V; Silva KP; Kiguti LRA; Rossi MA; Kettelhut IC; Pupo AS; Cunha FQ; Assreuy J
Am J Physiol Heart Circ Physiol; 2017 Jul; 313(1):H149-H163. PubMed ID: 28526706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
